InvestorsHub Logo
Post# of 252198
Next 10
Followers 833
Posts 119841
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 234155

Wednesday, 03/23/2022 5:07:22 PM

Wednesday, March 23, 2022 5:07:22 PM

Post# of 252198
LGND spins off antibody-discovery business, which will reverse-merge with APAC SPAC:

https://www.businesswire.com/news/home/20220323005896/en

Ligand intends to distribute 100% of the equity in OmniAb to Ligand shareholders immediately prior to the business combination with APAC. The transaction will be effected through a “Reverse Morris Trust” transaction pursuant to which OmniAb will be spun-off to Ligand’s shareholders and simultaneously merged as a subsidiary of APAC. The transaction is expected to be tax-free to Ligand and its shareholders for U.S. federal income tax purposes, except for cash received in lieu of fractional shares. Upon the closing of the transaction, Ligand shareholders are expected to own approximately 75% to 84% of the combined company, depending on redemptions, which will be listed on the Nasdaq Global Markets under the ticker symbol “OABI”.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.